BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1173-1181
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1173
Table 2 Baseline characteristics of hypertensive patients n (%)
Endoscopic resection (n = 53)Subtotal gastrectomy (n = 244)Total gastrectomy (n = 54)P
Male36 (67.9)153 (62.7)41 (75.9)0.17
Age at treatment (yr, mean ± SE)65.2 ± 8.165.8 ± 8.566.3 ± 9.30.79
Comorbid DM5 (9.4)46 (18.9)13 (24.1)0.13
Cardiovascular medication
Lipid lowering agent8 (15.1)52 (21.3)13 (24.1)0.49
Antithrombotic agent22 (41.5)93 (38.1)22 (40.7)0.87
Other1 (1.9)5 (2.0)2 (3.7)0.85
Antihypertensive agent
Calcium channel blocker (C)41 (77.4)166 (68.0)33 (61.1)0.19
Diuretics (D)19 (35.8)92 (37.7)21 (38.9)0.95
Beta-blocker (B)19 (35.8)76 (31.1)17 (31.5)0.80
ACEi or ARB (A)15 (28.3)82 (33.6)18 (33.3)0.75
Combination (A, D)9 (17.0)41 (16.8)5 (9.3)0.37
Combination (B, D)0 (0.0)9 (3.7)1 (1.9)0.54
Combination (A, C)0 (0.0)6 (2.5)3 (5.6)0.19
Antihypertensive medications (n)
118 (33.3)73 (29.9)16 (30.2)0.70
225 (46.3)97 (39.8)22 (41.5)
≥ 311 (20.4)74 (30.3)15 (28.3)


Write to the Help Desk